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Abstract
In recent decades, the decline in human fertility has become increasingly more worrying: while therapeutic
interventions might help, they are vexing for the couple and often burdened with high failure rates and
costs. Prevention is the most successful approach to fertility disorders in males and females alike. We performed a
literature review on three of the most common unhealthy habits – tobacco, alcohol and drug addiction – and their
reported effects on male fertility. Tobacco smoking is remarkably common in most first-world countries; despite a
progressive decline in the US, recent reports suggest a prevalence of more than 30% in subjects of reproductive age
– a disturbing perspective, given the well-known ill-effects on reproductive and sexual function as well as general
health. Alcohol consumption is often considered socially acceptable, but its negative effects on gonadal function have
been consistently reported in the last 30 years. Several studies have reported a variety of negative effects on
male fertility following drug abuse – a worrying phenomenon, as illicit drug consumption is on the rise, most
notably in younger subjects. While evidence in these regards is still far from solid, mostly as a result of several confounding
factors, it is safe to assume that cessation of tobacco smoking, alcohol consumption and recreational drug addiction might
represent the best course of action for any couple trying to achieve pregnancy.
Background
Almost 15% of all couples trying to conceive are affected
by infertility, and in almost half of these cases male
infertility is the sole or a contributing factor [1]. The
decline of male fertility is not an empty threat: evidence
points at a steadily progressive decline of sperm concen-
tration over the past 35 years [2]. These reports have
rekindled the interest in the potential impact of environ-
mental factors and lifestyle on fertility: in order to
decrease the social costs of male infertility and the
resulting burdens on public health, identifying prevent-
able factors is of the utmost importance. Sedentary be-
havior and obesity have both been associated with
impaired male fertility [3, 4] and have often been
addressed as potentially preventable factors; a more
detailed review on the effects of sports and physical
activity on male fertility is included in this Special Issue.
The role of other unhealthy lifestyles, such as smoking
and alcohol consumption, and environmental stressors
on general health is universally recognized, but their ef-
fects on male fertility are less known [5]. Indeed, male
reproductive health may be a sensitive marker of pollu-
tion [6] and environmental exposures [7, 8]. For ethical
reasons, interventional studies in regards to the effects
of tobacco use, second-hand smoking, recreational drug
abuse and alcohol consumption are generally not feas-
ible in humans. The vast majority of studies on these
topics are therefore retrospective [8]. Sadly, this leads to
a wide array of confounders, for which control is limited.
A partial solution comes from animal studies; however,
exposure in these models is significantly higher than in
humans, and as such results should be interpreted with
caution.
In order to provide an up-to-date and reliable refer-
ence in regards to the possible role of alcohol, tobacco
and recreational drugs on male fertility, we performed a
thorough review of existing literature and gathered all
necessary data.* Correspondence: andrea.sansone@uniroma1.it
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Causes of male infertility
Couple infertility is defined by the failure to achieve
pregnancy after at least 12 months of regular, unpro-
tected intercourse. On the other hand, providing a fitting
definition for male infertility is a more difficult task:
diagnosis is traditionally based on semen analysis results,
compared to the World Health Organization reference
values [9].
Successful spermatogenesis is the result of the
complex interaction between endocrine, paracrine and
autocrine factors [10]. Unsurprisingly, several acquired
and congenital conditions might impair the fine mecha-
nisms involved in spermatogenesis (Table 1). Acquired
testicular failure, as often observed following testicular
torsion, orchitis, or administration of cytotoxic treat-
ment is often associated with azoospermia. Varicocele,
testicular trauma, and medications might affect fertility,
although in most circumstances the spermatogenesis is
impaired to a lesser extent. Genetic abnormalities, such
as Klinefelter Syndrome or microdeletions in the AZF
(azoospermia factor) region on the human male Y chromo-
some, usually manifest with azoospermia; however, small
nucleotide polymorphisms are being investigated as a pos-
sible cause of “idiopathic” oligo-azoospermia. However,
despite the recent discoveries in regards to the genetics of
male infertility, to the present date most causes of
oligozoospermia remain unknown.
Age is significantly associated with decline in semen
quality, supposedly as a result of continued replications
from mutated spermatogonial stem cells [11]. DNA frag-
mentation and chromatin condensation might also play
a role in the pathogenesis of male infertility [12]. Among
non-genetic causes of male infertility, oxidative stress
resulting from exaggerated production of reactive
oxygen species (ROS) is perhaps the most known factor.
ROS are needed for capacitation, the acrosome reaction
and ultimately fertilization; however, reduced clearance
and excessive production are both able to induce DNA
damage and defective membrane integrity in sperm cells,
therefore resulting in reduced fertility potential [13].
Semen from fertile men has a more effective antioxidant
capacity than that from infertile men; furthermore,
immature teratozoospermic forms produce relatively
more ROS than normal, mature sperm [13]. Inflamma-
tory processes and vascular diseases, including varico-
cele, can supposedly increase ROS production: a
thorough evaluation aimed to assess the presence of
predisposing conditions is mandatory in the evaluation
of any infertile male.
Tobacco smoking and male fertility
More than 60% of noncommunicable diseases list smok-
ing among their risk factors, and every year more than
six million deaths result from tobacco consumption and
second-hand smoke [14]. Despite the growing body of
evidence supporting its deleterious effects, smoking is
still a widespread phenomenon, as proven by recent re-
ports from the World Health Organization. More than
one-third of all male adults worldwide use tobacco [15];
similarly, approximately 30% of women of reproductive
age smoke cigarettes [16]. Europe is still the leading con-
tinent in regards to tobacco use, whereas smoking rates
have gradually declined in the United States in recent
years [17].
Clinical studies
The deleterious effects of smoking on fertility have been
described since 1983: Olsen and colleagues identified to-
bacco use as one of the causes of otherwise unexplained
infertility in more than 1000 females [18]. To the present
date, more than 4700 different chemicals have been
identified in tobacco smoke [19], ranging from heavy
metals to polycyclic aromatic hydrocarbons to muta-
genic chemicals. A significant association between sem-
inal plasma lead levels and lifetime smoking estimate
has been reported [20]; likewise, smoking is considered
the most common source of lead and cadmium exposure
[21]. Some metal micronutrients involved in the patho-
genesis of oxidative stress and male infertility, including
arsenic and the aforementioned cadmium and lead, are
routinely inhaled during combustion of tobacco or
cigarette paper [21]. These metals all have mutagenic
properties and are similarly associated with increased
Table 1 Possible acquired causes of male reproductive
impairment
Hypothalamic-pituitary axis
Compressive effect (Pituitary or brain tumors)
Ablative effect (CNS surgery or radiotherapy)
Infiltrative effect (fungal infections, sarcoidosis, hemochromatosis)
Suppressive effect (exogenous AAS)
Quantitative alterations of spermatogenesis
Varicocele
Previous chemotherapy or radiotherapy
Testicular failure (torsion, orchitis, orchiectomy)
Comorbidities (liver and kidney disease)
Qualitative alterations of spermatogenesis
Oxidative stress
DNA damage
Ductal obstructions
Surgery (vasectomy, hernia repair, pelvic surgery)
Neurological disorders (Multiple Sclerosis, Spinal Cord Injury, neural
tube defects)
Erectile or ejaculatory dysfunction
Abbreviations: CNS central nervous system, AAS anabolic-androgenic steroid.
Edited from H Tournaye, C Krausz and RD Oates [10]
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risk of male infertility, despite no significant differences
in semen volume, concentration, and motility [22, 23].
On the other hand, impairments in sperm parameters
have been observed in many studies in the last decades
[24, 25]: in most of them, alterations in morphology and
decreased concentration, motility and viability have been
observed among smokers. A significant decrease in
sperm concentrations of current smokers compared with
those who had never smoked has been observed in a
meta-analysis of more than 2500 men from five separate
studies [26]. Similarly, Kunzle and colleagues have found
a significant association between smoking and reduced
sperm concentration in 2100 men presenting for fertility
evaluation [27].
Mechanisms resulting in impaired sperm parameters
have been investigated, but definite evidence is still miss-
ing. Ultra-structural abnormalities, mostly affecting axo-
nemal microtubules and tail alterations, have been
reported in heavy smokers [28, 29]; similarly, smoking
impairs the acrosome reaction [30] and capacitation
[31], two processes ultimately needed for fertilization.
Increased oxidative stress has been suggested as a pos-
sible mechanism resulting in impaired sperm functions.
Hypoxia resulting from cigarette smoking might also be
responsible for impaired spermatogenesis, even more
dramatically in patients with varicocele [8, 32].
Mitochondrial activity and chromatin structure in hu-
man sperm might be impaired by several toxins, there-
fore negatively affecting fertilization capacity both in
vivo and in vitro [17, 33, 34].
Hypothetically, chronic cigarette smoking increases
liver metabolism of testosterone, while at the same time
inducing secretory dysfunction of Leydig and Sertoli
cells [24]. However, there seems to be no general con-
sensus on the effects of smoking on FSH and LH pro-
duction: some studies have shown lower levels of both
gonadotropins among smokers, whereas different re-
searchers have observed increased concentration of LH
and/or FSH following tobacco consumption [35, 36].
Considering all the possible confounding factors, testos-
terone concentration is remarkably difficult to ascertain
among smokers: some studies have reported increased
serum testosterone and dehydroepiandrosterone levels
in smokers [35, 37], whereas others have suggested that
mean levels of testosterone are not significantly different
[38] between smokers and non-smokers.
The American Society of Reproductive Medicine in
2012 stated that “semen parameters and results of sperm
function tests are 22% poorer in smokers than in non-
smokers and the effects are dose-dependent” [16]. More
recently, a meta-analysis study on a grand total of 5865
subjects has concluded that moderate and heavy
smokers are more likely to have reduced sperm count
and motility [17]. Evidence suggests a significant role for
cigarette smoking on spermatogenesis, but on the other
hand the impact of smoking on male fertility has yet to
be fully elucidated. A preventive approach to infertility,
suggesting smoking cessation and reduction of second-
hand smoking in both women and men, should be
suggested.
Experimental studies
Animal studies
Cigarette smoking results in accumulation of
benzo(a)pyrene (B[a]P) and cotinine, ultimately leading
to DNA damage and testicular cytotoxicity in rodent
models. In a recent study, Esakky and colleagues [39] re-
ported significantly decreased expression of aryl hydrocar-
bon receptor (Ahr), and enhanced expression of Fas, FasL,
BCL2, and activated caspase-3 proteins in testes exposed
to cigarette smoke condensate. The reduced expression of
Ahr increases susceptibility of germ cells to polycyclic aro-
matic hydrocarbons, while the remaining proteins all in-
duce apoptosis via extrinsic (FAS, FASL) or mitochondrial
processes (BCL, caspase-3). Tobacco use is also closely as-
sociated to reduced antioxidant activity, therefore worsen-
ing the effects of oxidative stress [40].
Exposure to cigarette smoke also impairs the activity
of sorbitol dehydrogenase and lactate dehydrogenase,
reflecting the effects on spermatogenesis and sperm
maturation in rats [41]. Most importantly, histomorpho-
logical alterations of testes, significantly increased abnor-
malities in epidydimal spermatozoa and sperm DNA
damage have been observed in rats exposed to cigarette
smoke [41, 42]. In both in vitro and in vivo studies, nico-
tine resulted involved in direct impairment of sperm
motility and in apoptosis induction in rat Leydig cells
[43]. Mice exposed to cigarette smoke also underwent
alterations in cell signal pathway networks, including
ERK1/2, nuclear factor-κB and several protein kinases
involved in spermatogenesis; furthermore, modified
DNA methylation patterns were observed near tran-
scriptional start sites for the PEBP1 gene. Expression of
PEBP1 results in production of
phosphatidylethanolamine-binding protein 1, a protein
that in humans has been shown to interact with C-Raf,
MAP2K1 and MAPK1 [44].
High doses of nicotine induce a significant decrease in
sperm count and motility in prepubertal and adult rats
exposed to progressively increasing concentrations of
nicotine [45]. Impaired testicular function is also
reflected in significantly decreased testosterone levels
[45, 46], although as previously suggested it’s still un-
clear whether these findings are valid for humans as well
as rodents.
Smoking cessation, on the other hand, improves indi-
ces of sexual health for long-term male smokers [47]
and, based on finding in animal models, might improve
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sperm parameters [48]. However, to the present date, no
conclusive evidence on the real improvements in male
fertility following smoking cessation has been obtained.
Studies in humans
Recent genome-wide studies have identified alterations
in the methylation profile of 95 sites in smokers [49].
Smoking-related DNA damage and methylation patterns
are observed in several human tissues - even those who
are not directly exposed to it because of indirect sys-
temic exposure [50]. DNA adducts and DNA damage
are inversely associated with sperm parameters, mostly
concentration and motility, and both are transmitted to
the zygote with little chance of repair by the ovum [51].
Sperm DNA fragmentation is also linked with increased
rates of spontaneous abortion [52] and should therefore
be carefully assessed in subjects undergoing assisted
reproduction techniques. Oxidative DNA damage [53]
and higher cadmium levels [54] resulting from tobacco
consumption are similarly associated to impaired fertil-
ity, resulting in longer time to pregnancy for couples.
Smoking also reduces sperm creatine kinase activity,
therefore impairing sperm motility and energy homeo-
stasis [55]. In vitro studies have shown nicotine, cotinine
and cadmium as possible culprits; in vivo, both smoking
duration and amount of cigarettes smoked per day seem
able to reduce creatine kinase activity in sperm [56, 57].
Alcohol consumption and male fertility
Clinical and experimental studies have examined alcohol
consumption as a potential risk factor for male infertil-
ity, exerting a direct effect on both testosterone metabol-
ism and spermatogenesis.
Clinical studies
The link between alcohol and fertility was investigated
in 1985 for the first time. The analysis of seminal fluid
samples and the hormonal evaluation of 20 men with al-
cohol dependence syndrome revealed a significant de-
crease in testosterone levels, seminal fluid volume and
sperm concentration in chronic alcoholics than in con-
trols [58]. Subsequently, a prospective autopsy study
showed that a significant percentage of heavy drinkers
(52.3%) had partial or complete spermatogenic arrest,
and that the mean testicular weight of heavy drinkers
was slightly but significantly lower compared with that
of controls [59]. Muthusami et al., in 2005, found in
chronic alcoholics a significant increase of FSH, LH, and
E2 levels, while testosterone was significantly decreased.
Semen volume, sperm count, motility, and number of
morphologically normal sperm were significantly de-
creased [60]. In 2011 one meta-analysis including 57
studies and 29,914 subjects found a significant
association between alcohol, semen volume, sperm
morphology and sperm motility [61].
Therefore, chronic and excessive alcohol intake seem
to have a detrimental effect on male reproductive hor-
mones and on semen quality. Conversely, the effect of
moderate alcohol intake is still under debate.
A cross sectional study from Jensen et al. on 8344
healthy men suggest that moderate alcohol intake
(median weekly intake 8 units) is not adversely associ-
ated with semen quality in healthy men, whereas it was
associated with higher serum testosterone levels [62].
Furthermore, chronic alcohol consumption seem to in-
fluence fertility more than acute alcohol consumption.
Hansen et al. evaluated the association between last
5 days of alcohol intake, semen quality and reproductive
hormones in a cross-sectional study among 347 men
[63]. Alcohol intake was associated with impairment of
most semen characteristics but without a coherent
dose–response pattern. There was a tendency towards
lower semen characteristics at higher intake of alcohol
past 5 days and a hormonal shift towards higher estra-
diol/testosterone ratio. The importance of the timing of
alcohol consumption was also established from Condorelli
et al. The Authors retrospectively evaluated semen and
hormonal parameters of moderate alcohol users, compar-
ing occasional drinkers with daily drinkers. Within each
group, a further comparison was made between the fertile
subjects (pregnancy over the past 12 months) and the in-
fertile patients (no evidence of pregnancy or fertilisation
for at least 12 months). The results showed that infertile
patients belonging to group of ‘daily drinkers’ have a
semen quality and hormonal characteristics significantly
worse compared with the other groups [64]. Time-to-
pregnancy for was significantly longer in couples in which
the male partner consumed more than 20 units of alcohol
on a weekly basis [65], but literature is severely lacking
concerning more moderate consumption of alcoholic
beverages.
The mechanisms underlying the damage of alcohol on
fertility are not yet fully clarified. Close and colleagues
reported that current heavy alcohol users have signifi-
cantly higher leukocyte concentrations in the seminal
fluid compared with nonusers. After controlling for past
sexually transmitted diseases and multiple substance ex-
posures in a multivariate model, alcohol users had only a
trend towards increased leukocytes in the seminal fluid
[66]. Some Authors hypothesized that also maternal al-
cohol consumption during pregnancy can influence
semen quality in the male offspring. From a cohort of
Danish pregnant women established in 1984–1987, 347
young adult sons were selected for a follow-up study
conducted in 2005–2006. The results of this study
showed that the sperm concentration decreased with in-
creasing prenatal alcohol exposure. No associations were
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found for sperm motility, sperm morphology, or any of
the reproductive hormones, including testosterone [67].
Experimental studies
Animal studies
Alcohol consumption has often been associated with an
increase in β-endorphin levels that could be involved in
testicular damage, inducing sperm apoptosis. In 1999
Yin and colleagues showed that morphine induces the
expression of the protein Fas (also known as CD95 or
APO-1), a receptor on the cell surface that triggers the
cell’s suicide by apoptosis when it binds to its ligand,
FasL [68]. Furthermore, an experimental study demon-
strated that treatment with naloxone and naltrexone in
adult and pubertal male rats could prevent alcohol-
induced testosterone inhibition [69].
Apoptosis is one of the responsible factors for sperm-
atozoal chromatin disorders. Several studies showed that
ethanol consumption disturb nuclear maturity and DNA
integrity of spermatozoa. Talebi and colleagues evaluated
the effect of ethanol consumption on sperm parameters
and chromatin integrity of spermatozoa aspirated from
cauda epididymis of rats. Results revealed that sperm
progressive and non progressive motility of ethanol-
consuming rats were significantly decreased compared
with control animals and an alteration of nuclear
maturity and DNA integrity [70].
Therefore, spermatogenic cells undergo apoptosis
when treated with ethanol but the mechanism remain
unclear. In the study of Jana and colleagues, intra-
peritoneal injection of ethanol induced apoptotic sper-
matogenic cell death with a decrease in the plasma and
intra-testicular testosterone in adult male mice. In this
study, western blot analysis revealed that repeated etha-
nol treatment decreased the expression of steroidogenic
acute regulatory protein (StAR), 3b-hydroxysteroid de-
hydrogenase (3b-HSD) and 17b-hydroxysteroid dehydro-
genase (17b-HSD); increased the expression of active
caspase-3, p53, Fas and Fas-L; and led to up-regulation
of Bax/Bcl-2 ratio and translocation of cytochrome c
from mitochondria to cytosol in testis. Moreover, re-
peated ethanol treatment led to upregulation of caspase-
3, p53, Fas and Fas-L transcripts; increase in caspase-3
and caspase-8 activities; diminution of 3b-HSD,
17b-HSD and GPx activities; decrease in the
mitochondrial membrane potential along with ROS gen-
eration and depletion of glutathione pool in the
testicular tissue [71].
Studies in humans
Polycyclic aromatic hydrocarbons (PAH) are ubiquitous
pollutants in the environment, which are able to form
DNA adducts when they are activated to DNA reactive
metabolites. Measurement of DNA adducts is a widely
used marker of DNA damage induced by environmental
pollutants. Gaspari and colleagues evaluated data on
(PAH)-DNA adducts in 182 men with morphological ab-
normalities in the sperm, finding a significant negative
association was between daily alcohol consumption and
PAH-DNA adducts in sperm [72]; similarly, Rossi and
colleagues reported that increased alcohol consumption
was associated with fertilization failure and reduced live
birth rates [73], with a 21% decline in couples in which
both partners drank more than 4 units per week. On the
contrary, in the study of Horak et al., no correlation be-
tween alcohol and sperm DNA adducts was found [74].
Finally, Loft evaluated the level of oxidative DNA dam-
age in terms of 7-hydro-8-oxo-20-deoxyguanosine
(8-oxodG) in sperm DNA among 225 first-pregnancy
planners and the 8-oxodG level was not significantly
associated with consumption of alcohol [53].
Finally, the genetic background may modulate the im-
pact of alcohol on spermatogenesis. The glutathione
S-transferase (GST)-M1 genotype may be associated
with a greater susceptibility to develop, via direct mech-
anism at testicular level, alcohol-induced spermatogen-
esis disorders. An autopsy study comprising 271 subjects
showed that among 50 moderate drinking men, 48% had
partial and 10% complete spermatogenic arrest. Among
the 21 men with normal spermatogenesis, 42.9% had
GST M1 genotype with a frequency similar to that found
in men with partial or complete spermatogenic arrest
(44.8%). Among the 212 heavy-drinking men, 21.2% of
the subjects had normal spermatogenesis, 36.3% had
partial spermatogenic arrest, 38.2% showed complete ar-
rest spermatogenic arrest and 4.2% showed Sertoli cell-
only syndrome. Interestingly, 27 of the 45 heavy drinkers
with normal spermatogenesis (60%) men had the GST
M1 genotype. The finding that >20% of heavy drinkers
had normal spermatogenesis suggests that the GST M1
genotype exerts a protective effects on alcohol-induced
spermatogenesis disorders [75].
Drugs addiction and male fertility
Up to almost one in four men under the age of 35 years
uses recreational drugs [76]. Several studies have sug-
gested that these drugs might have adverse effects on
human reproduction. Cannabis smoking has been shown
to negatively impact male fertility, with an effect on
hypothalamus-pituitary-gonadal axis, spermatogenesis,
and sperm function, as cannabinoid receptors are
expressed in the anterior pituitary, Leydig cells, Sertoli
cells and in testicular tissues [77]. Similarly, negative ef-
fects on male fertility have been reported in subjects
using cocaine, MDMA (ecstasy) and opioids. Cocaine
use has been associated with other high-risk behaviors,
such as tobacco smoking and sexually transmitted
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diseases, and might lead to testicular cell apoptosis; opi-
oids act on the HPG axis, possibly resulting in hypo-
gonadal hypogonadism; DNA damage and tubular
degeneration have been described in rats treated with
MDMA. Prevention of male infertility might be achieved
by identifying and addressing the consequences of the
“illicit drug epidemic”.
Clinical studies
In literature, human data on hormone levels following
marijuana exposure are conflicting. Referring to animal
studies it could be possible that consuming cannabis
decrease serum luteinizing hormone and testosterone
levels, but in clinical studies a univocal interpretation is
lacking.
A study from Kolodny et al. on 20 men who used
marijuana chronically showed significantly lower levels
of plasma testosterone in this group than that in the
control-group. Decreased testosterone was dose related.
Abstention from marijuana use or stimulation with hu-
man chorionic gonadotropin during continued mari-
huana use produced marked increases in testosterone
[78]. These results have been later contradicted. In 66
males neither chronic nor acute intake of marijuana had
a significant effect on plasma testosterone levels, but
also subjects who drank cannabis as a tea were included
[79]. In a study of 27 men, no statistically significant
changes in plasma testosterone levels were observed
during and after the smoking period as compared with
the pre-smoking base-line levels [80]. In four healthy
males subjects, cannabis smoking significantly depressed
plasma LH, while cortisol significantly increased [81].
On the contrary, in the study from Gundersen et al. on
1215 Danish healthy young men, of whom 45% had
smoked marijuana during the past 3 months, marijuana
use was associated with increased serum testosterone to
the same level as cigarette smoking [82].
Conversely, regarding the effect of cannabis on sperm-
atogenesis, clinical studies showed an effect on volume,
number morphology, motility, and fertilization capacity.
In the study from Gundersen et al. regular use of
marijuana was found to be associated with an impair-
ment in semen quality, while irregular use seems to be
irrelevant [82]. A study from Hembree et al. showed an
association between marijuana use and decreased sperm
count, which persisted in the following 4-week recovery
period [83]. These data were confirmed also by a case
study on a multidrug addict, in which semen abnormal-
ities were detected before and 2 years after cessation of
the abuse [84]. In a recent unmatched case-referent
study with 1700 participants, it was clearly reported that
cannabis exposure is a risk factor for poor sperm
morphology [85]. Only one study on 159 men
attending an infertility clinic demonstrated a positive
correlation between marijuana use and percentage of
motile sperm [66].
There are no studies on the effect of cannabis on the re-
productive organs of men. Only Kolodny et al. reported
no change in testicular size and texture in chronic
marijuana users [78]. The differing results of these reports
may in part be due to study design, the ingestion of other
pharmacological agents, such as narcotics, alcohol and
cigarette smoking.
Cocaine intake during pregnancy severely affects fetal
development; however, little is known in regards to its
effects on male fertility. The same applies to MDMA
(Ecstasy): animal models might help understand the spe-
cific effects of both substances on male fertility. Bracken
et al. [86] reported increased use of cocaine among sub-
jects with lower sperm counts and motility; Samplaski
et al. [87] more recently suggested that the higher rates
of concurrent substance abuse, tobacco use and infec-
tions among cocaine users might lead to biased results.
Opioids act on the hypothalamic-pituitary axis by inhi-
biting the pulsatility of GnRH secretion: the resulting
suppression of FSH and LH release consequently leads
to impaired spermatogenesis and reduced testosterone
concentrations [76]. Vuong et al. [88] performed a
lengthy review of the effects of opioids on endocrine pa-
rameters, and concluded that there is still insufficient in-
formation on the long-term effects of opioids in regards
to fertility despite concrete evidence of opioid-induced
hypogonadism. Recent reports suggest that both sperm
concentration and quality are impaired in opioid
abusers: increased rates of DNA fragmentation and re-
duced expression of catalase-like and superoxide
dismutase-like activity were observed in addict men
compared to age-matched healthy volunteers [89].
Experimental studies
Animal studies
Acute treatments with cannabinoids can decrease the
fertilising capacity of sea urchin sperm [90]. In rodent
studies, high THC doses caused a modest increase in ab-
normally formed sperm. Moreover, long-term cannabin-
oid exposure in male mice disrupted spermatogenesis
and induced aberrations in sperm morphology [91].
Wenger and colleagues showed that THC alters pituit-
ary LH release by inhibiting the release of LHRH, inject-
ing THC into the third cerebral ventricle of male rats
[92]. Smith et al. [93] found a significant decrease in
serum testosterone concentration following acute doses
of THC in rhesus monkeys. A study on adult male mice
showed regressive changes in the testes and suppressed
sperm count, viability and motility, caused by chronic in-
take of bhang. Bhang intake also caused significant
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Table 2 Effects of tobacco smoking, alcohol consumption and drug addiction on spermatogenesis and sperm parameters
Studies in humans Animal studies
Tobacco
smoking
Reduction of sperm concentration [26, 27]
Impairment of sperm motility [17]
Increase in ultra-structural abnormalities (axonemal
microtubules and tail alterations) [28, 29]
Impairment of mitochondrial activity and chromatin structure [17, 33, 34]
Impairment of acrosome reaction and capacitation [30, 31]
Increase of DNA methylation patterns [49]
Alterations in ERK1/2, nuclear factor-κB signal pathway [44]
Reduction of creatine kinase activity in sperm [55–57]
Increase in apoptosis via extrinsic (FAS, FASL) or
mitochondrial processes (BCL, caspase-3) in rats [39, 40]
Reduction of antioxidant activity in rats [40]
Increase in DNA damage in sperm rats [41, 42]; of DNA
methylation patterns PEBP1 gene in rats [44]
Reduction of sperm count and motility in rats [45]
Alcohol
consumption
Reduction of seminal volume and sperm concentration [58, 61, 62]
Impairment of sperm motility and morphology [60, 61]
Increased sperm polycyclic aromatic hydrocarbon DNA adducts [72]
Increase in apoptosis (by upregulation of Fas) of
spermatogenic cells in rats [68]
Alteration of nuclear maturity and DNA integrity in
sperm cells of rats [70]
Increase in ROS generation and depletion of
glutathione pool in testicular tissue of rats [71]
Impairment of sperm motility in rats [70]
Drug addiction
Marijuana Decrease in sperm count [82–84]
Impairment of sperm morphology and motility [85, 102, 103]
Reduction of spontaneous acrosome reactions [102, 103]
Impaired sperm concentration and morphology in rats
[91]
Inhibition of sperm ATP production in rats [104]
Reduction of fructose and citric acid contents in testis
and prostate of male rats [95]
Cocaine Impairment of sperm counts and motility [86] Vasoconstriction of testicular blood vessels in rats
resulting in ischemic and reperfusion injuries [96]
Reduction of diameter of seminiferous tubules [97]
Decrease in number of total germ cells [97]
Increase in oxidative stress in mice [98]
Opioids Impaired spermatogenesis [76]
Increased rates of DNA fragmentation in humans [89]
Reduced expression of catalase-like and superoxide
dismutase-like activity [89]
Increase of rates of DNA damage and tubular
degeneration in rats [100, 101]
Amphetamines
and Ecstasy
No data available Vasoconstriction of testicular blood vessels in rats [96]
Increase in rates of DNA damage and tubular
degeneration in rats [99]
Table 3 Effects of tobacco smoking, alcohol consumption and drug addiction on hormone levels
Studies in humans Animal studies
Tobacco smoking Increase in liver metabolism of testosterone [24]
Reduction of LH and/or FSH levels [34]
Increase in concentration of LH and/or FSH [35]
Increase in serum testosterone and DHEA levels [35, 37]
Reduction of testosterone levels in rats [45, 46]
Alcohol
consumption
Decrease in testosterone levels [58, 59]
Increase in FSH, LH, and E2 levels [60]
Decrease in plasma and intra-testicular testosterone in
rats [71]
Drug addiction
Marijuana Decrease in levels of plasma testosterone [78]
Decreased levels of plasma LH, and increased levels of plasma cortisol
[81]
Increased serum testosterone [82]
Inhibition of LHRH release in rats [92]
Decrease in testosterone levels in monkeys [93]
Cocaine Increase in LH levels without modifying testosterone following acute
administration [97]
Increase in LH levels; No effects on testosterone and
estradiol in rats [97]
Opioids Inhibition of the pulsatility of GnRH secretion; reduction of LH, FSH and
testosterone levels [76]
Reduction of LH, without effect on FSH and testosterone
levels in rats [101]
Amphetamines
and Ecstasy
No data available No effects on LH, FSH, Testosterone levels in male rats
[99]
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decline in circulating testosterone level due to decline in
testicular 3b HSD enzyme activity, a significant variation
in the CB1 and CB2 receptors and FAAH protein levels
(Fatty Acid Amide Hydrolase) in testes of mice exposed
to bhang [94]. Finally, repeated subcutaneous administra-
tion of cannabis extract and delta-9-tetrahydrocannabinol
reduced significantly fructose and citric acid contents of
male reproductive organs of prepubertal as well as adult
albino rats in a dose-related manner in the testis, prostate
as well as in the epididymis [95].
Effects of cocaine and MDMA on fertility have been
evaluated in animal models: in rodents, cocaine is able
to induce prolonged vasoconstriction of testicular blood
vessels, resulting in ischemic and reperfusion injuries
[96]. In 1996, George et al. reported that in rats
long-term exposure to cocaine resulted in reduced
diameter of seminiferous tubules and similarly de-
creased number of total germ cells [97]. More re-
cently, increased oxidative stress has been observed in
mice following chronic administration of cocaine [98],
suggesting a possible mechanism for testicular dam-
age. Similar findings have been reported for Ecstasy
and opioids: Barenys et al. described significantly de-
creased sperm concentration and motility, together
with increased rates of DNA damage and tubular de-
generation, in rats treated with varying dosages of
MDMA [99], and similar findings have been described
in mice treated with either tramadol [100] or
morphine [101].
Studies in humans
Whan et al. investigated the effects of delta-9-
tetrahydrocannabinol (THC) on human sperm function
in vitro. Both therapeutic and recreational levels of THC
determined a dose dependent reduction of sperm motil-
ity and of spontaneous acrosome reactions [102].
Subsequent studies confirmed these results [103], but
the mechanism still remained not fully understood. Morgan
et al. investigated the effects of WIN 55,212-2, a CB1 can-
nabinoid receptor agonist, and D9-tetrahydracannabinol
(D9-THC) on the ATP levels and motility of murine sperm
in vitro. High concentrations of WIN 55,212-2 or D9-THC
inhibit ATP production in sperm; this effect of WIN
55,212-2 is CB1 receptor dependent whereas that of
D9-THC is not [104].
Conclusions
Despite the lack of solid evidence from interventional
studies, which are for the most part not feasible in
humans, it is clear that smoking, alcohol use and
recreational drug consumption are somehow able to
impair male fertility, with possible synergistic, rather
than addictive, effects. Impairments in spermatogenesis
and sperm parameters as well as increased DNA
methylation and oxidative stress have been observed
in humans and animal models alike; similarly, effects
on endocrine control of reproductive and sexual
function have been reported in clinical and
Fig. 1 Effects of smoking, alcohol and drug abuse on spermatogenesis (left) and hormonal parameters (right) in males
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experimental studies (Tables 2 and 3, Fig. 1). Discon-
tinuation of all these habits should be suggested in all
patients undergoing investigation for infertility in
order to provide the best outcomes, although little is
known in regards to the time needed for cessation of
negative effects.
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